Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 2 8Phase 3 4Phase 1 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 125INDUSTRY 90NIH 55NETWORK 7OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2CNS 1

Conditions

Melanoma 6Lymphoma, B-Cell 5Uveal Melanoma 4Esophageal Neoplasms 4Colorectal Neoplasms 4Recurrence 3Polycystic Ovary Syndrome 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Follicular 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1

Interventions

Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER_GOV × Colonic Neoplasms × Clear all
NCT03507699 2023-04-18

Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer

Sheba Medical Center

Phase 1 Completed
19 enrolled
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Colonic Neoplasms

NCT04270461 2020-10-22

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Jiujiang University Affiliated Hospital

Phase 1 Withdrawn
CNSGastrointestinal

Colonic Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡